Results 251 to 260 of about 1,626,624 (288)

The pharmacogenetics of the selective serotonin reuptake inhibitors

The Clinical Investigator, 1993
Citalopram, fluoxetine, fluvoxamine, paroxetine and sertraline are selective serotonin reuptake inhibitors (SSRIs), which are thought to act as antidepressants through their ability to inhibit presynaptic serotonin reuptake in the brain. The elimination of the SSRIs proceeds predominantly via oxidation catalyzed by cytochrome P450 in the liver ...
openaire   +2 more sources

Selective Serotonin Reuptake Inhibitors

2016
Selective serotonergic reuptake inhibitors (SSRIs) are a class of medications used frequently to address issues related to stroke and post-stroke recovery. Health care providers who care for stroke patients will need to familiarize themselves with their applications in stroke treatment.
Ali Saad, Patrick Nguyen, Samir R. Belagaje   +2 more
openaire   +2 more sources

Not So Selective Serotonin Reuptake Inhibitors

The Journal of Clinical Psychiatry, 1998
Venlafaxine norepinephrine reuptake dopamine reuptake BRAINSTORMS is a monthly section of The Journal of Clinical Psychiatry aimed at providing updates of novel concepts emerging from the neurosciences that have relevance to the practicing psychiatrist.
openaire   +2 more sources

Selective Serotonin Reuptake Inhibitors

PharmacoEconomics, 1996
Depression is a common and significant health problem associated with impairment in a patient's ability to function in their role (e.g. student, worker, home-maker), and may have a fatal outcome in the case of suicide. Recently there has been progress in developing new antidepressant medications, such as the selective serotonin reuptake inhibitors ...
openaire   +2 more sources

Selective Serotonin Reuptake Inhibitors

2011
Selective serotonin reuptake inhibitors (SSRIs) are one of the newer classes of antidepressants. Since their introduction in the United States, they have been greatly used and accepted in the psychiatric field (1). SSRIs presently available in the United States include fluoxetine, paroxetine, sertraline, fluvoxamine, and citalopram.
openaire   +1 more source

SELECTIVE SEROTONIN REUPTAKE INHIBITORS IN OCD

Clinical Neuropharmacology, 1992
S A, Montgomery, T, Bullock, N, Fineberg, D, Montgomery   +3 more
openaire   +2 more sources

Selective Serotonine Reuptake Inhibitors

2000
Hemmen die Wiederaufnahme des Serotonins in die Nervenzelle, die es freigesetzt hat, um uber den synaptischen Spalt (zwischen zwei Nervenzellen) hinweg den Impuls auf die nachste Nervenzelle zu ubertragen. Innerhalb der Nervenzellen werden die Impulse elektrisch weitergeleitet.
openaire   +1 more source

Selective Serotonin Reuptake Inhibitors and Adverse Effects: A Narrative Review

Neurology International, 2021
Amber Edinoff, Ivan Urits, Adam Kaye
exaly  

Selective serotonin reuptake inhibitors and serotonin–norepinephrine reuptake inhibitors as adjuncts for postoperative pain management: systematic review and meta-analysis of randomised controlled trials

British Journal of Anaesthesia, 2022
Jane Jomy, Rachel Couban, James Paul
exaly  

Selective Serotonin Reuptake Inhibitors and Autism

American Journal of Therapeutics, 2016
Tina J, Walch, Amanda, Tinkelman
openaire   +2 more sources